Literature DB >> 12926169

Peritoneal cytology and preoperative serum CA 125 level are important prognostic indicators of overall survival in advanced endometrial cancer.

Markku Santala1, Anne Talvensaari-Mattila, Antti Kauppila.   

Abstract

BACKGROUND: The current study aimed to evaluate flow cytometry findings, peritoneal cytology and preoperative CA 125 level as prognostic factors of endometrial carcinoma. PATIENTS AND METHODS: A retrospective study of 44 patients with FIGO stage II-IV endometrial carcinoma who underwent abdominal hysterectomy, bilateral salpingo-oophorectomy and, all except three, pelvic lymph node dissection. At operation, a peritoneal washing sample was taken for cytological examination. Flow cytometry was performed on fresh primary tumor samples. Blood samples were obtained within 2 weeks before surgery. The median follow-up time was 54 months.
RESULTS: In univariate analysis, DNA ploidy, S-phase fraction, serum CA 125 level and peritoneal cytological findings correlated significantly with survival. In multivariate analysis, peritoneal cytology (benign versus malignant), grade (1 + 2 versus 3) and preoperative serum CA 125 concentration (< or = 25 U/ml versus > 25 U/ml) remained significant independent predictors of overall survival. DNA ploidy and S-phase fraction had a strong correlation with peritoneal cytology. Malignant cytological findings were more frequent in cases with DNA aneuploidy and S-phase fraction higher than 8%.
CONCLUSION: In addition to histological grade, peritoneal cytology and preoperative serum CA 125 level were also important independent prognostic indicators of outcome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12926169

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Determination of CA-125 levels in the serum, cervical and vaginal secretions, and endometrium in Chinese women with precancerous disease or endometrial cancer.

Authors:  Shu-Ming He; Fuqi Xing; Hong Sui; Youming Wu; Yongli Wang; Dong Wang; Guanghui Chen; Zijing Kong; Shu-Feng Zhou
Journal:  Med Sci Monit       Date:  2011-11

2.  Preoperative serum CA125: a useful marker for surgical management of endometrial cancer.

Authors:  Tao Jiang; Ling Huang; Shulan Zhang
Journal:  BMC Cancer       Date:  2015-05-12       Impact factor: 4.430

3.  Utility of Preoperative CA125 Assay in the Management Planning of Women Diagnosed with Uterine Cancer.

Authors:  N Povolotskaya; N Das; K Dhar; D Brinkmann; F Gardner; R Woolas
Journal:  Surg Res Pract       Date:  2014-02-27

Review 4.  The significance of markers in the diagnosis of endometrial cancer.

Authors:  Monika M Żyła; Jacek R Wilczyński; Marta Kostrzewa; Kinga Księżakowska-Łakoma; Marek Nowak; Grzegorz Stachowiak; Krzysztof Szyłło; Tomasz Stetkiewicz
Journal:  Prz Menopauzalny       Date:  2016-11-15

5.  Efficacy of endocervical curettage and CA-125 measurement in endometrial serous carcinoma: A case series and literature review.

Authors:  Ahmet Cem İyibozkurt; Murat Doğan; Ercan Baştu; Hamdullah Sözen; Doğan Vatansever; Samet Topuz; Sinan Berkman
Journal:  Turk J Obstet Gynecol       Date:  2015-09-15

6.  Intraperitoneal cytology after laparoscopic hysterectomy in patients with endometrial cancer: A retrospective observational study.

Authors:  Tomohito Tanaka; Yoshito Terai; Kazuya Maeda; Keisuke Ashihara; Yuhei Kogata; Hiroshi Maruoka; Shinichi Terada; Takashi Yamada; Masahide Ohmichi
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

Review 7.  The Complementary Role of Imaging and Tumor Biomarkerszzm321990in Gynecological Cancers: An Update of the Literature

Authors:  Emanuela Anastasi; Silvia Gigli; Laura Ballesio; Antonio Angeloni; Lucia Manganaro
Journal:  Asian Pac J Cancer Prev       Date:  2018-02-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.